购物车
- 全部删除
- 您的购物车当前为空
CL-82198 是 MMP-13选择性抑制剂。它能够与 MMP-13 的整个 S1' 口袋结合,这是其对 MMP-13 选择性和对其他 MMP 缺乏抑制活性的基础。它可用于研究骨关节炎。
CL-82198 是 MMP-13选择性抑制剂。它能够与 MMP-13 的整个 S1' 口袋结合,这是其对 MMP-13 选择性和对其他 MMP 缺乏抑制活性的基础。它可用于研究骨关节炎。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥ 253 | 现货 | |
5 mg | ¥ 412 | 现货 | |
10 mg | ¥ 690 | 现货 | |
25 mg | ¥ 1,480 | 现货 | |
50 mg | ¥ 2,390 | 现货 | |
100 mg | ¥ 3,990 | 现货 | |
200 mg | ¥ 5,690 | 现货 | |
500 mg | ¥ 8,490 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 453 | 现货 |
产品描述 | CL-82198, a selective MMP-13 inhibitor, serves as a pharmacological intervention to halt the progression of osteoarthritis (OA). Its mechanism of action involves binding to the S1’ pocket of MMP-13, ensuring its selectivity and preventing inhibition of other MMPs. |
体外活性 | CL-82198 decreases CTGF and TGF-β1 protein levels in hepatic stellate cells[3]. CL-82198 (10 μM; 24 hours) obviously reduces LS174 cell migration[1]. |
体内活性 | CL82198 (1-10 mg/kg; i.p.; every other day for 12 weeks) treatment avoids and decelerates MLI-induced osteoarthritis progression. |
分子量 | 302.37 |
分子式 | C17H22N2O3 |
CAS No. | 307002-71-7 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 100 mg/mL (330.72 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.